Main menu button

News

Carlsquare advised Feelgood Shop on the sale to Finexx
09 feb 2020
Carlsquare advised Feelgood Shop on the sale to Finexx
Deal News
Carlsquare advised spend analytics software technology company Orpheus GmbH on the sale to McKinsey
06 feb 2020
Carlsquare advised spend analytics software technology company Orpheus GmbH on the sale to McKinsey
Deal News
Analysis SBB: Increased earnings capacity following take-over bid
06 feb 2020
Analysis SBB: Increased earnings capacity following take-over bid
Equity Research
Carlsquare advised the shareholders of Meridian Spa & Fitness Deutschland GmbH on the sale to David Lloyd Leisure (DLL)
03 feb 2020
Carlsquare advised the shareholders of Meridian Spa & Fitness Deutschland GmbH on the sale to David Lloyd Leisure (DLL)
Deal News
Carlsquare advises 7Mind on the investment from Südwestdeutsche Medienholding
21 jan 2020
Carlsquare advises 7Mind on the investment from Südwestdeutsche Medienholding
Deal News
Analysis Follicum: Countdown to new hair loss trials
05 dec 2019
Analysis Follicum: Countdown to new hair loss trials
Equity Research
Analysis MultiDocker: Divestment of Brazilian subsidiary adds cash
05 dec 2019
Analysis MultiDocker: Divestment of Brazilian subsidiary adds cash
Equity Research
Analysis Cantargia: Surprisingly strong data
03 dec 2019
Analysis Cantargia: Surprisingly strong data
Equity Research
Analysis Consilium: Slightly better than anticipated in Q3 2019
02 dec 2019
Analysis Consilium: Slightly better than anticipated in Q3 2019
Equity Research
Analysis Ecoclime: Focus to sell energy saving products
25 nov 2019
Analysis Ecoclime: Focus to sell energy saving products
Equity Research
Analysis Amasten: Increased focus following divestment
21 nov 2019
Analysis Amasten: Increased focus following divestment
Equity Research
Analysis Expres2ion: Good potential with reduced risk
21 nov 2019
Analysis Expres2ion: Good potential with reduced risk
Equity Research
Analysis Flowscape: Break-even reached
20 nov 2019
Analysis Flowscape: Break-even reached
Equity Research
Analysis Precise Biometrics: Approaching profitability
18 nov 2019
Analysis Precise Biometrics: Approaching profitability
Equity Research
Analysis Aspire: Attractive valuation
13 nov 2019
Analysis Aspire: Attractive valuation
Equity Research
Analysis, Verisec: Freja eID increasing its pace
12 nov 2019
Analysis, Verisec: Freja eID increasing its pace
Equity Research
Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes
12 nov 2019
Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes
Deal News
Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes
12 nov 2019
Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes
Deal News
Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes
12 nov 2019
Carlsquare advised on Bifodan's sale to Deerland Probiotics & Enzymes
Deal News
Analysis Fastator: No NAV discount following share price increase
11 nov 2019
Analysis Fastator: No NAV discount following share price increase
Equity Research